Cargando…
The impact of Rhodiola rosea on biomarkers of diabetes, inflammation, and microbiota in a leptin receptor-knockout mouse model
Type 2 diabetes is the most prevalent endocrine disease in the world, and recently the gut microbiota have become a potential target for its management. Recent studies have illustrated that this disease may predispose individuals to certain microbiome compositions, and treatments like metformin have...
Autores principales: | Jafari, Mahtab, Juanson Arabit, Jasmin Grace, Courville, Robert, Kiani, Dara, Chaston, John M., Nguyen, Cindy Duy, Jena, Nilamani, Liu, Zhong-Ying, Tata, Prasanthi, Van Etten, Richard A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9217815/ https://www.ncbi.nlm.nih.gov/pubmed/35732671 http://dx.doi.org/10.1038/s41598-022-14241-7 |
Ejemplares similares
-
Rhodiola rosea Improves Lifespan, Locomotion, and Neurodegeneration in a Drosophila melanogaster Model of Huntington's Disease
por: Arabit, Jasmin G. J., et al.
Publicado: (2018) -
The impact of Rhodiola rosea on the gut microbial community of Drosophila melanogaster
por: Labachyan, Khachik E., et al.
Publicado: (2018) -
Extension of Drosophila Lifespan by Rhodiola rosea through a Mechanism Independent from Dietary Restriction
por: Schriner, Samuel E., et al.
Publicado: (2013) -
Lifespan extension and delay of age-related functional decline caused by Rhodiola rosea depends on dietary macronutrient balance
por: Gospodaryov, Dmytro V, et al.
Publicado: (2013) -
Rhodiola rosea: A Therapeutic Candidate on Cardiovascular Diseases
por: Chen, Yingqing, et al.
Publicado: (2022)